SOTIO to Present New Data on the IL-15 superagonist SO-C101 at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

by NASDAQ Market News November 4, 2020

NASDAQ Market News
Click here to email author

CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition

IoT Technologies with Advanced Artificial Intelligence to Redefine COVID-19 Care Management

Ads